Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy.
D000818:Animals; D001640:Bicuculline / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D003837:Deoxy Sugars / Q000378:metabolism*; D003847:Deoxyglucose / Q000378:metabolism*; D004553:Electric Conductivity; D005947:Glucose / Q000378:metabolism; D007608:Kainic Acid / Q000494:pharmacology*; D008297:Male; D009928:Organ Specificity; D010433:Pentylenetetrazole / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D012640:Seizures / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology*
D003837:Deoxy Sugars; D011759:Pyrrolidines; D003847:Deoxyglucose; D005947:Glucose; D007608:Kainic Acid; D010433:Pentylenetetrazole; D001640:Bicuculline